Non-host-reactive donor CD8+ T cells of Tc2 phenotype potently inhibit marrow graft rejection

Blood

Volumn 91, Issue 11, 1998, Pages 4045-4050

  Fowler, Daniel H ^a,b   Whitfield, Bernard ^a   Livingston, Michael ^a   Chrobak, Paul ^a   Gress, Ronald E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ALLOGRAFT; ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOLYSIS; GENE DELETION; GRAFT REJECTION; HAPLOTYPE; HOST RESISTANCE; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION;

EID: 0032101011     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4045.411k17_4045_4050     Document Type: Article

References (26)

1. Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 3:445, 1988
2. Martin PJ: Determinants of engraftment after allogeneic marrow transplantation [editorial]. Blood 79:1647. 1992
3. Martin PJ: Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans. J Exp Med 178:703, 1993
4. Korngold R, Sprent J: Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol 135:3004, 1985
5. Champlin R, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, Reichert T: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia. Transplant Proc 23:1695, 1991
6. Croft M, Carter L, Swain SL, Dutton RW: Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180:1715, 1994
7. Sad S, Marcotte R, Mosmann TR: Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2:271, 1995
8. Fowler DH, Breglio J, Nagel G, Eckhaus M, Gress RE: Allospecific CD8+ Tc1 and Tc2 populations in GVL and GVHD. J Immunol 157:4811, 1996
9. Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL: Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155: 585,1995
10. Fowler DH, Breglio J, Nagel G, Gress RE: Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: Type I cells generate GVL, type II cells abrogate GVL. Biol Blood Marrow Transplant 2:118, 1996
11. Fink PJ, Shimonkevitz RP, Bevan MJ: Veto cells. Annu Rev Immunol 6:115, 1988
12. Hiruma K, Nakamura H, Henkart PA, Gress RE: Clonal deletion of postthymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J Exp Med 175:863, 1992
13. Nakamura H, Gress RE: Interleukin 2 enhancement of veto suppressor cell function in T-cell-depleted bone marrow in vitro and in vivo. Transplantation 49:931, 1990
14. Martin PJ: Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: Potential role of a veto mechanism. Blood 88:962, 1996
15. Carter LL, Dutton RW: Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol 155:1028, 1995
16. Lowenthal JW, MacDonald HR: Expression of interleukin 1 receptors is restricted to the L3T4+ subset of mature T lymphocytes. J Immunol 138:1, 1987
17. Carlesso N, Griffin JD, Druker BJ: Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 9:149, 1994
18. Wunderlich J, Shearer G: Induction and measurement of cytotoxic T lymphocyte activity, in Coligan JE, Kruisbeek AM, Marguilies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology (ed 1). New York, NY, Wiley, 1992, p 3.11.4
19. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY: Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271, 1988
20. Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML: Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J Immunol 122:2491, 1979
21. Simms PE, Ellis TM: Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diag Lab Immunol 3:301, 1996
22. Reisner Y, Ben-Bassat I, Douer D, Kaploon A, Schwartz E, Ramot B: Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation. Proc Natl Acad Sci USA 83:4012, 1986
23. Donohue J, Homge M, Kernan NA: Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 82:1023, 1993
24. Davenport C, Kumar V, Bennett M: Rapid rejection of H2k and H21/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice. J Immunol 155:3742, 1995
25. Nakamura H, Gress RE: Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrow. Transplantation 49:453, 1990
26. Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT: Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and-syngeneic tumors. J Exp Med 182:477, 1995